A multicenter phase II study of docetaxel, gemcitabine and trastuzumab administration as first-line treatment in patients with advanced breast cancer (ABC) overexpressing HER-

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 728-728 ◽  
Author(s):  
A. Polyzos ◽  
D. Mavroudis ◽  
J. Boukovinas ◽  
E. Tsiakopoulos ◽  
N. Malamos ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Line Treatment ◽  
First Line ◽  
Multicenter Phase ◽  
First Line Treatment

scholarly journals Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study

2018 ◽  
Vol 109 (3) ◽  
pp. 803-813 ◽  
Author(s):  
Norikazu Masuda ◽  
Reiki Nishimura ◽  
Masato Takahashi ◽  
Kenichi Inoue ◽  
Shinji Ohno ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document